Cargando…

Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study

BACKGROUND: Standard treatment for malignant peritoneal mesothelioma has not been established, and systemic chemotherapy is administered according to malignant pleural mesothelioma. We previously reported the efficacy of cisplatin plus pemetrexed as first-line chemotherapy; however, the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitadai, Rui, Shimoi, Tatsunori, Sudo, Kazuki, Noguchi, Emi, Nagata, Yusuke, Sawada, Ryoichi, Takashima, Atsuo, Boku, Narikazu, Yonemori, Kan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980334/ https://www.ncbi.nlm.nih.gov/pubmed/33743636 http://dx.doi.org/10.1186/s12885-021-08025-x

Ejemplares similares

Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study
por: Iizumi, Sakura, et al.
Publicado: (2018)

High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study
por: Takamizawa, Shigemasa, et al.
Publicado: (2022)

Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population
por: Noda-Narita, Shoko, et al.
Publicado: (2019)

Breast Cancer Brain Metastasis—Overview of Disease State, Treatment Options and Future Perspectives
por: Watase, Chikashi, et al.
Publicado: (2021)

Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment
por: Watanuki, Rurina, et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective study
por: Takamizawa, Shigemasa, et al.
Publicado: (2022)

High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer
por: Yazaki, Shu, et al.
Publicado: (2022)

Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers
por: Shimoi, Tatsunori, et al.
Publicado: (2021)

Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)

Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study
por: Takamizawa, Shigemasa, et al.
Publicado: (2022)

Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study
por: Ishikawa, Masashi, et al.
Publicado: (2021)

PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system
por: Shimoi, Tatsunori, et al.
Publicado: (2018)

Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors
por: Takeyasu, Yuki, et al.
Publicado: (2021)

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
por: Sanomachi, Tomomi, et al.
Publicado: (2023)

Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer
por: Yazaki, Shu, et al.
Publicado: (2022)

Peritoneal Malignant Psammomatous Mesothelioma
por: Pusiol, Teresa, et al.
Publicado: (2010)

Travel Time and Distance and Participation in Precision Oncology Trials at the National Cancer Center Hospital
por: Uehara, Yuji, et al.
Publicado: (2023)

Development of a Detection System for ESR1 Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping
por: Kojima, Yuki, et al.
Publicado: (2023)

The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary Site
por: Sato, Jun, et al.
Publicado: (2019)

Treatment of Patients with Malignant Peritoneal Mesothelioma
por: Li, Claire Y., et al.
Publicado: (2022)

Recurrent malignant peritoneal mesothelioma treated by a second resection: A case report
por: Miyata, Takashi, et al.
Publicado: (2023)

Malignant Peritoneal Mesothelioma Presenting with Polymyalgia Rheumatica-like Syndrome
por: Ide, Yuka, et al.
Publicado: (2020)

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study
por: Iizumi, Sakura, et al.
Publicado: (2017)

Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy
por: Iizumi, Sakura, et al.
Publicado: (2017)

Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer
por: Mizuno, Takaaki, et al.
Publicado: (2020)

HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix
por: Mizuno, Takaaki, et al.
Publicado: (2020)

Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
por: Watanabe, Sho, et al.
Publicado: (2023)

Malignant Peritoneal Mesothelioma Mimicking Ischemic Colitis
por: Mitsuka, Yuusuke, et al.
Publicado: (2010)

Malignant peritoneal mesothelioma. Is there a new treatment?
por: Rasul, Kakil Ibrahim, et al.
Publicado: (2009)

Malignant Peritoneal Mesothelioma Presenting as Mucinous Ascites
por: Field, Zachary, et al.
Publicado: (2018)

Malignant Peritoneal Mesothelioma Mimicking Recurrent Diverticulitis
por: Robalino Gonzaga, Ernesto S, et al.
Publicado: (2019)

Malignant Peritoneal Mesothelioma Without Asbestos Exposure
por: Abbas, Hafsa, et al.
Publicado: (2019)

Unusual radiologic presentations of malignant peritoneal mesothelioma
por: Sugarbaker, Paul Hendrick, et al.
Publicado: (2020)

Malignant Peritoneal Mesothelioma with Latent Tuberculosis Infection
por: Inoue, Naonori, et al.
Publicado: (2021)

Malignant peritoneal mesothelioma—a diagnostic challenge
por: Abdul Razzak, Saad, et al.
Publicado: (2022)

Malignant Peritoneal Mesothelioma: A Case Report
por: Sousa, Bárbara, et al.
Publicado: (2023)

Diffuse malignant peritoneal mesothelioma: A review
por: Sun, Luanbiao, et al.
Publicado: (2023)

Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy
por: Yazaki, Shu, et al.
Publicado: (2022)

Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma
por: Kojima, Yuki, et al.
Publicado: (2023)

Peritoneal Mesothelioma in a High Volume Peritoneal Surface Malignancies Unit
por: Pereira, Fernando, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dk0l4n1e1vegdmgeehl04uaqtv